252 related articles for article (PubMed ID: 32829656)
1. Endothelial-to-Mesenchymal Transition and Inflammation Play Key Roles in Cyclophilin A-Induced Pulmonary Arterial Hypertension.
Xue C; Senchanthisai S; Sowden M; Pang J; White RJ; Berk BC
Hypertension; 2020 Oct; 76(4):1113-1123. PubMed ID: 32829656
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation.
Xue C; Sowden M; Berk BC
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1138-1146. PubMed ID: 28450293
[TBL] [Abstract][Full Text] [Related]
3. ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport.
Liu B; Azfar M; Legchenko E; West JA; Martin S; Van den Haute C; Baekelandt V; Wharton J; Howard L; Wilkins MR; Vangheluwe P; Morrell NW; Upton PD
Cardiovasc Res; 2024 May; 120(7):756-768. PubMed ID: 38626311
[TBL] [Abstract][Full Text] [Related]
4. E2F1 Mediates SOX17 Deficiency-Induced Pulmonary Hypertension.
Yi D; Liu B; Ding H; Li S; Li R; Pan J; Ramirez K; Xia X; Kala M; Ye Q; Lee WH; Frye RE; Wang T; Zhao Y; Knox KS; Glembotski CC; Fallon MB; Dai Z
Hypertension; 2023 Nov; 80(11):2357-2371. PubMed ID: 37737027
[TBL] [Abstract][Full Text] [Related]
5. Basigin mediates pulmonary hypertension by promoting inflammation and vascular smooth muscle cell proliferation.
Satoh K; Satoh T; Kikuchi N; Omura J; Kurosawa R; Suzuki K; Sugimura K; Aoki T; Nochioka K; Tatebe S; Miyamichi-Yamamoto S; Miura M; Shimizu T; Ikeda S; Yaoita N; Fukumoto Y; Minami T; Miyata S; Nakamura K; Ito H; Kadomatsu K; Shimokawa H
Circ Res; 2014 Sep; 115(8):738-50. PubMed ID: 25149188
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.
Van Hung T; Emoto N; Vignon-Zellweger N; Nakayama K; Yagi K; Suzuki Y; Hirata K
Life Sci; 2014 Nov; 118(2):313-28. PubMed ID: 24412382
[TBL] [Abstract][Full Text] [Related]
7. IL-13 enhances mesenchymal transition of pulmonary artery endothelial cells via down-regulation of miR-424/503 in vitro.
Takagi K; Yamakuchi M; Matsuyama T; Kondo K; Uchida A; Misono S; Hashiguchi T; Inoue H
Cell Signal; 2018 Jan; 42():270-280. PubMed ID: 29102771
[TBL] [Abstract][Full Text] [Related]
8.
Park CS; Kim SH; Yang HY; Kim JH; Schermuly RT; Cho YS; Kang H; Park JH; Lee E; Park H; Yang JM; Noh TW; Lee SP; Bae SS; Han J; Ju YS; Park JB; Kim I
Circ Res; 2022 Oct; 131(10):792-806. PubMed ID: 36205124
[TBL] [Abstract][Full Text] [Related]
9. In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug.
Hopper RK; Moonen JR; Diebold I; Cao A; Rhodes CJ; Tojais NF; Hennigs JK; Gu M; Wang L; Rabinovitch M
Circulation; 2016 May; 133(18):1783-94. PubMed ID: 27045138
[TBL] [Abstract][Full Text] [Related]
10. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
Life Sci; 2019 Jun; 227():64-73. PubMed ID: 31004656
[TBL] [Abstract][Full Text] [Related]
11. Acetylated cyclophilin A is a major mediator in hypoxia-induced autophagy and pulmonary vascular angiogenesis.
Mao M; Yu X; Ge X; Gu R; Li Q; Song S; Zheng X; Shen T; Li X; Fu Y; Li J; Zhu D
J Hypertens; 2017 Apr; 35(4):798-809. PubMed ID: 28079595
[TBL] [Abstract][Full Text] [Related]
12. Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension.
Liang OD; So EY; Egan PC; Goldberg LR; Aliotta JM; Wu KQ; Dubielecka PM; Ventetuolo CE; Reginato AM; Quesenberry PJ; Klinger JR
Cardiovasc Res; 2017 Nov; 113(13):1560-1573. PubMed ID: 29016733
[TBL] [Abstract][Full Text] [Related]
13. The effect of honokiol on pulmonary artery endothelium cell autophagy mediated by cyclophilin A in hypoxic pulmonary arterial hypertension.
Wang X; Xiao D; Ma C; Zhang L; Duan Q; Zheng X; Mao M; Zhu D; Li Q
J Pharmacol Sci; 2019 Mar; 139(3):158-165. PubMed ID: 30770282
[TBL] [Abstract][Full Text] [Related]
14. Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.
Szulcek R; Sanchez-Duffhues G; Rol N; Pan X; Tsonaka R; Dickhoff C; Yung LM; Manz XD; Kurakula K; Kiełbasa SM; Mei H; Timens W; Yu PB; Bogaard HJ; Goumans MJ
Angiogenesis; 2020 Nov; 23(4):699-714. PubMed ID: 32813135
[TBL] [Abstract][Full Text] [Related]
15. Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension.
Rodor J; Chen SH; Scanlon JP; Monteiro JP; Caudrillier A; Sweta S; Stewart KR; Shmakova A; Dobie R; Henderson BEP; Stewart K; Hadoke PWF; Southwood M; Moore SD; Upton PD; Morrell NW; Li Z; Chan SY; Handen A; Lafyatis R; de Rooij LPMH; Henderson NC; Carmeliet P; Spiroski AM; Brittan M; Baker AH
Cardiovasc Res; 2022 Aug; 118(11):2519-2534. PubMed ID: 34528097
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic acid ameliorates pulmonary hypertension via inhibition of tyrosine kinase Fyn.
Kurahara LH; Hiraishi K; Yamamura A; Zhang Y; Abe K; Yahiro E; Aoki M; Koga K; Yokomise H; Go T; Ishikawa K; Bo Z; Kishi H; Kobayashi S; Aoki-Shoi N; Toru S; Inoue R; Hirano K
J Mol Cell Cardiol; 2020 Nov; 148():50-62. PubMed ID: 32889002
[TBL] [Abstract][Full Text] [Related]
17. Lineage Tracing Reveals the Dynamic Contribution of Pericytes to the Blood Vessel Remodeling in Pulmonary Hypertension.
Bordenave J; Tu L; Berrebeh N; Thuillet R; Cumont A; Le Vely B; Fadel E; Nadaud S; Savale L; Humbert M; Huertas A; Guignabert C
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):766-782. PubMed ID: 31969018
[TBL] [Abstract][Full Text] [Related]
18. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
[TBL] [Abstract][Full Text] [Related]
19. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
[TBL] [Abstract][Full Text] [Related]
20. Flk1 Deficiency and Hypoxia Synergistically Promote Endothelial Dysfunction, Vascular Remodeling, and Pulmonary Hypertension.
Akiyama T; Sadahiro T; Yamada Y; Fujita R; Abe Y; Nakano K; Honda S; Ema M; Kubota Y; Sakai S; Hizawa N; Ieda M
Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):1668-1683. PubMed ID: 37534464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
